ResearcherSecond Affiliated Hospital of Nanchang UniversityNo recent work listed

Hou‐Qun Ying

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3858-4761; OpenAlex author ID A5018317039. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2018: 1 paper

Papers 1

Significance of combined preoperative serum Alb and dNLR for diagnosis of pancreatic cancer. Last author DOI 10.2217/fon-2017-0339 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ang Li · 1 shared paper, 2018 · strength 0.09
- Paper Significance of combined preoperative serum Alb and dNLR for diagnosis of pancreatic cancer. DOI 10.2217/fon-2017-0339 ↗
Jiaxin Liu · 1 shared paper, 2018 · strength 0.09
- Paper Significance of combined preoperative serum Alb and dNLR for diagnosis of pancreatic cancer. DOI 10.2217/fon-2017-0339 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.